ReShape Lifesciences Q3 EPS $(3.11) Up From $(59.36) YoY; Revenue $2.292M Up From $2.155M YoY
ReShape Lifesciences Q3 EPS $(3.11) Up From $(59.36) YoY; Revenue $2.292M Up From $2.155M YoY
reshape lifesciences 第三季度每股收益 $(3.11) 同比上升自 $(59.36); 營業收入 $229.2萬 同比上升自 $215.5萬
ReShape Lifesciences Q3 EPS $(3.11) Up From $(59.36) YoY; Revenue $2.292M Up From $2.155M YoY
reshape lifesciences 第三季度每股收益 $(3.11) 同比上升自 $(59.36); 營業收入 $229.2萬 同比上升自 $215.5萬
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。